REGENEUS LTD (ASX:RGS)
Industry: Classification Pending
Activity: Regenerative medicine.
77 Ridge Street GORDON NSW 2072
Ph: (02) 9499 8010    Fax: (02) 9499 8020
Duncan Thomson
Wed, 13 Nov 2013 1:30pm
Duncan Thomson, Head of Animal Health
Icon_lastIcon_nextIcon_previousIcon_first
Annual General Meeting
Tue, 28 Oct 2014
Full Year Results
Mon, 25 Aug 2014
Interim Results
Thu, 27 Feb 2014
Annual General Meeting
Wed, 27 Nov 2013
Response to 7.30 media commentary Thu, 9 Oct 2014
Trading Halt Tue, 7 Oct 2014
Notice of Annual General Meeting/Proxy Form Thu, 25 Sep 2014
RGS receives R&D tax incentive refund of $3.7m Thu, 25 Sep 2014
HiQCell Regenerative Medicine Clinic to open in Singapore Tue, 23 Sep 2014
Kvax cancer vaccine available in Australia, US trial begins Thu, 11 Sep 2014
Appendix 3B - Issue of Shares Wed, 10 Sep 2014
Share Purchase Plan closes oversubscribed Tue, 9 Sep 2014
Date of AGM Fri, 29 Aug 2014
AFL approves use of Regeneus' stem cell therapy, HiQCell Wed, 27 Aug 2014

Please note: This company appears on this website as a result of its listing on the Australian Securities Exchange. BRR Media does not claim any association with any company listed on this site.